Mary E Norton

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Follow-up of sonographically detected soft markers for fetal aneuploidy
    Mary E Norton
    Stanford University School of Medicine, 300 Pasteur Drive, HH333, Stanford, CA 94305 Electronic address
    Semin Perinatol 37:365-9. 2013
  2. doi request reprint Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University Lucile Packard Children s Hospital, CA 94305, USA
    Am J Obstet Gynecol 207:137.e1-8. 2012
  3. doi request reprint Effects of changes in prenatal aneuploidy screening policies in an integrated health care system
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University School of Medicine Lucile Packard Children s Hospital, Stanford, California 94305, USA
    Obstet Gynecol 121:265-71. 2013
  4. pmc Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context
    Megan Allyse
    Stanford Center for Biomedical Ethics, Stanford, CA 94305 5417, USA
    Hum Reprod 27:3123-31. 2012
  5. doi request reprint Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University School of Medicine Lucile Packard Children s Hospital, Stanford, California 94305, USA
    Obstet Gynecol 121:847-50. 2013
  6. doi request reprint Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening
    Shilpa Chetty
    Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA
    Prenat Diagn 33:542-6. 2013
  7. ncbi request reprint Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis
    Aaron B Caughey
    Department of Obstetrics and Gynecology, University of California, San Francisco, USA
    Am J Obstet Gynecol 187:1239-45. 2002
  8. pmc Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation
    Lauren C Sayres
    Stanford Center for Biomedical Ethics, Stanford University, Stanford, CA 94301, USA
    Prenat Diagn 31:1070-6. 2011
  9. pmc A first look at chorioamnionitis management practice variation among US obstetricians
    Mara B Greenberg
    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Lucile Packard Children s Hospital at Stanford, Stanford University, 300 Pasteur Drive HH333, Stanford, CA 94305, USA
    Infect Dis Obstet Gynecol 2012:628362. 2012

Detail Information

Publications9

  1. doi request reprint Follow-up of sonographically detected soft markers for fetal aneuploidy
    Mary E Norton
    Stanford University School of Medicine, 300 Pasteur Drive, HH333, Stanford, CA 94305 Electronic address
    Semin Perinatol 37:365-9. 2013
    ....
  2. doi request reprint Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University Lucile Packard Children s Hospital, CA 94305, USA
    Am J Obstet Gynecol 207:137.e1-8. 2012
    ..We sought to evaluate performance of a noninvasive prenatal test for fetal trisomy 21 (T21) and trisomy 18 (T18)...
  3. doi request reprint Effects of changes in prenatal aneuploidy screening policies in an integrated health care system
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University School of Medicine Lucile Packard Children s Hospital, Stanford, California 94305, USA
    Obstet Gynecol 121:265-71. 2013
    ..To estimate changes in rates of prenatal testing for aneuploidy over a 5-year period in a large integrated health care system...
  4. pmc Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context
    Megan Allyse
    Stanford Center for Biomedical Ethics, Stanford, CA 94305 5417, USA
    Hum Reprod 27:3123-31. 2012
    ..We argue that there is an urgent need for policy-makers, regulators and professional societies to provide guidance on the most efficient and ethical manner for such tests to be introduced into clinical practice in the USA...
  5. doi request reprint Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University School of Medicine Lucile Packard Children s Hospital, Stanford, California 94305, USA
    Obstet Gynecol 121:847-50. 2013
    ..True cost-utility analyses will be needed to determine the actual clinical efficacy of this approach in the general prenatal population...
  6. doi request reprint Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening
    Shilpa Chetty
    Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA
    Prenat Diagn 33:542-6. 2013
    ..The aim of this study was to investigate how the introduction of noninvasive prenatal testing (NIPT) impacted women's testing choices following a positive prenatal screening (PNS) result...
  7. ncbi request reprint Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis
    Aaron B Caughey
    Department of Obstetrics and Gynecology, University of California, San Francisco, USA
    Am J Obstet Gynecol 187:1239-45. 2002
    ..The purpose of this study was to perform a cost-effectiveness analysis that compared the first- and second- trimester screening tools for Down syndrome...
  8. pmc Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation
    Lauren C Sayres
    Stanford Center for Biomedical Ethics, Stanford University, Stanford, CA 94301, USA
    Prenat Diagn 31:1070-6. 2011
    ..To provide a preliminary assessment of obstetric healthcare provider opinions surrounding implementation of cell-free fetal DNA testing...
  9. pmc A first look at chorioamnionitis management practice variation among US obstetricians
    Mara B Greenberg
    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Lucile Packard Children s Hospital at Stanford, Stanford University, 300 Pasteur Drive HH333, Stanford, CA 94305, USA
    Infect Dis Obstet Gynecol 2012:628362. 2012
    ..This may represent a dearth of level I evidence. Future prospective clinical trials may provide more evidence-based practice recommendations for diagnosis and treatment of chorioamnionitis...